Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early 2020 ...
In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects ...
Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD ...
Bacillus Calmette-Guérin (BCG) vaccine is the live attenuated vaccine form of Mycobacterium bovis used to prevent tuberculosis and other mycobacterial infections. Now, using zebrafish “avatars,” a ...
Humans are protected by two branches of the immune system. Innate immunity provides built-in defense against widespread characteristics of bacteria and viruses, while adaptive immunity memorizes ...
Bacillus Calmette-Guérin (BCG) is one of the world’s oldest and most widely used vaccines. It was developed in the early 20th century to provide protection from tuberculosis. Surprisingly, this ...
Tuberculosis is a serious health threat, and the efficacy of the BCG vaccine against tuberculosis diminishes in adulthood, making booster vaccines a realistic option. Mycobacterial DNA-binding protein ...
Cabinet Secretary for health Debra Mulongo Barasa and Director General for Health Dr. Patrick Amoth addressing the media on scarcity of vaccines at Afya House,Nairobi. [ Jenipher Wachie, Standard] ...
Stakeholders in a procession along Uhuru highway during the launch of 'Mulika TB-Maliza TB' awareness campaign during the commemoration of World TB Day at Uhuru Park on Friday, March 24, 2016.[JONAH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results